Parker Waichman LLP Headlines by Topic
Zelnorm
FDA Asks Novartis to Suspend Marketing of GI Drug Zelnorm
Apr 2, 2007
| NewsInferno.com
The U.S. Food and Drug Administration (FDA) notified Novartis Pharmaceuticals Corporation that the company must cease its marketing of Zelnorm...
Zelnorm is taken off the market
Mar 31, 2007
| Los Angeles Times
A widely prescribed drug for severe constipation is being taken off the market after it was linked to a higher risk of heart attacks and strokes,...
Novartis to stop constipation drug sale
Mar 30, 2007
| AP
Swiss pharmaceutical maker Novartis AG will stop selling a drug to relieve constipation after it was linked to a higher chance of heart attack,...
FDA Announces Discontinued Marketing of GI Drug, Zelnorm, for Safety Reasons
Mar 30, 2007
| www.fda.gov
The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue...
FDA Finds Possible New Risks of Bowel Drug
Apr 28, 2004
| AP
Some users of the irritable-bowel treatment Zelnorm have suffered diarrhea so serious they require hospitalization, and four have died from an...
Page 1/1
